Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) Pragmatic Clinical Trial
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Anxiety, Anxiety, Chronic Pain, Depression, Insomnia Sleep Studies, Other Indications |
| Therapuetic Areas: | Musculoskeletal, Psychiatry / Psychology, Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/29/2019 |
| Start Date: | March 28, 2019 |
| End Date: | June 30, 2023 |
The Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) pragmatic clinical trial will
test the population-level implementation of validated approaches to detect and effectively
manage sleep disturbance, pain, anxiety, depression, energy deficit/fatigue, and functional
decline among patients with all types and stages of cancer using a cluster-randomized,
stepped wedge design.
test the population-level implementation of validated approaches to detect and effectively
manage sleep disturbance, pain, anxiety, depression, energy deficit/fatigue, and functional
decline among patients with all types and stages of cancer using a cluster-randomized,
stepped wedge design.
The Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) Pragmatic Clinical Trial tests
whether systematically assessing patient reported outcomes for sleep disturbance, pain,
anxiety, depression, and fatigue among patients with solid and liquid malignancies and using
these data to increase the frequency of guideline-concordant care by: 1) reporting these data
to their clinical teams, 2) providing patients with needs-matched symptom self-management
education, and 3) suggesting evidence-based symptom management strategies to their care teams
improves patients' quality of life, symptoms, and adherence to cancer treatment, while
reducing their unplanned use of healthcare resources. This population-based trial uses a
cluster-randomized, stepped wedge design to evaluate the full population of patients managed
within Mayo Clinic Midwest medical oncology practices irrespective of cancer type or stage.
whether systematically assessing patient reported outcomes for sleep disturbance, pain,
anxiety, depression, and fatigue among patients with solid and liquid malignancies and using
these data to increase the frequency of guideline-concordant care by: 1) reporting these data
to their clinical teams, 2) providing patients with needs-matched symptom self-management
education, and 3) suggesting evidence-based symptom management strategies to their care teams
improves patients' quality of life, symptoms, and adherence to cancer treatment, while
reducing their unplanned use of healthcare resources. This population-based trial uses a
cluster-randomized, stepped wedge design to evaluate the full population of patients managed
within Mayo Clinic Midwest medical oncology practices irrespective of cancer type or stage.
Inclusion Criteria:
- Undergoing treatment, or have undergone treatment, for cancer at a Mayo Clinic Midwest
medical oncology clinic.
Exclusion Criteria:
- Lack of English Fluency
- Membership in a vulnerable population - Prisoner
- Membership in a vulnerable population - Mentally handicapped
- Membership in a vulnerable population - Axis I psychiatric condition
We found this trial at
1
site
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
